Noro-Moseley Partners (NMP) is an Atlanta-based venture capital firm specializing in early growth equity investments for rapidly scaling B2B software and healthcare companies. Founded in 1983, NMP has a rich history of partnering with exceptional teams to foster business growth. Over the past two decades, the firm has invested approximately $450 million in more than 70 portfolio companies, demonstrating its deep domain expertise and commitment to supporting high-growth businesses.

NMP's investment philosophy centers on identifying companies with strong leadership, compelling unit economics, and significant market disruption potential. The firm typically invests between $5 million and $20 million in companies with a target revenue run rate of $2 million to $20 million and year-over-year growth exceeding 50%. NMP's portfolio spans various sectors, including enterprise software, healthcare IT, healthcare services, internet and IoT, security, software, and transportation.

Notable portfolio companies include Red Canary, Medix Infusion, Revenue Analytics, and Contessa. The firm's recent exits have collectively represented over $4 billion in enterprise value since 2015. NMP's team comprises experienced professionals with over 70 years of collective investment experience, providing valuable support beyond capital to help companies scale effectively.